Shu Liu joined the Thoracic oncology lab in Oct., 2012 as a postdoctoral fellow. Her main research interest here is small molecule drug development. She is participating in exciting drug discovery projects using computational chemistry methods to rationally design and optimize properties of drug candidates. She also characterizes compounds to understand their activities both in vitro and in vivo.

Photo by Marco Sanchez, UCSF Documents & Media

Liu has a Ph.D. in pharmaceutical sciences from College of Pharmacy, University of South Carolina in 2012. She received her Ph.D training from her advisor Dr. Campbell McInness in the drug design and synthesis lab. Liu's dissertation is entitled design of non-ATP competitive and cell cycle specific CDK inhibitors targeting cyclin binding groove.

She also has a B.S. in biological sciences from University of Science and Technology of China in 2005. Her college research work was about transdermal drug delivery.